European Commission Authorizes GSK ' s HIV Prevention Drug European Commission Authorizes GSK ' s HIV Prevention Drug

The European Commission has authorized cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news